Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
An. bras. dermatol ; 96(3): 352-354, May-June 2021. graf
Article in English | LILACS | ID: biblio-1285072

ABSTRACT

Abstract Cutaneous leishmaniasis is characterized by ulcers with raised edges and a granular bottom, mainly on the lower limbs. This is a case report of a male patient with an ulcer on the left plantar region. The diagnosis was confirmed by positive PCR for L. braziliensis and the presence of amastigotes of Leishmania sp. in the histopathological examination. After treatment with Glucantime, the patient showed full healing of the ulcer. The unusual location of the ulceration calls attention to atypical presentations of leishmaniasis, and the importance of histopathological examination and PCR, leading to the appropriate diagnosis and treatment.


Subject(s)
Humans , Male , Leishmania braziliensis , Leishmaniasis, Cutaneous/diagnosis , Leishmaniasis, Cutaneous/drug therapy , Foot Ulcer , Leishmania , Ulcer , Meglumine Antimoniate
2.
An. bras. dermatol ; 94(1): 9-16, Jan.-Feb. 2019. tab, graf
Article in English | LILACS | ID: biblio-983744

ABSTRACT

Abstract: Disseminated leishmaniasis is a severe and emerging form of American tegumentary leishmaniasis. Disseminated leishmaniasis is defined by the presence of more than 10 polymorphic cutaneous lesions, distributed over more than two noncontiguous parts of the body. Nasal mucosal involvement is observed in almost half of cases. Disseminated leishmaniasis patients present with a decreased production of Th1 cytokines in the peripheral blood due to the attraction of leishmania- activated T cells to the multiple cutaneous lesions. Disseminated leishmaniasis development is poorly understood and is related to a complex network involving environmental, host immune response, and parasite factors, in which L. braziliensis polymorphism plays an important role. Disseminated leishmaniasis is a challenging disease to cure, presenting a high failure rate of 75% to pentavalent antimony therapy. Despite its importance and severity, this form of American tegumentary leishmaniasis has been poorly studied and documented, deserving greater attention from professionals working in endemic areas.


Subject(s)
Humans , Leishmania braziliensis , Leishmaniasis, Cutaneous/pathology , Leishmaniasis, Cutaneous/drug therapy , Amphotericin B/therapeutic use , Treatment Outcome , Leishmaniasis, Cutaneous/immunology , Antiprotozoal Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL